Chinas weight-loss drug makers take on global giants as Novo Nordisk patent expires Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market Novo Nordisks blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals
This peptide is frequently investigated for its involvement in telomere-support pathways, oxidative-stress response mechanisms, circadian-rhythm signalling, and cellular-regeneration models
This hormone is secreted by placenta in a pregnant woman
1 Both medications can cause weight gain, so if youre taking Wegovy specifically for weight management, its worth discussing your overall medication plan with your prescriber
Adolescents may present with school absenteeism, mood changes, or gastrointestinal symptoms rather than classic pelvic pain
In studies, many patients experienced substantial body-weight reductions over months of consistent Tirzepatide use, with some losing more than 15 percent of starting weight when combined with lifestyle changes